Overview
Our mission & aim
Established in 1981, the Drug Safety Research Unit (DSRU) is a broad pharmacoepidemiological unit which monitors, studies and communicates the safety and risk-benefit balance of medicines and vaccines.
Our Mission: To protect public health by studying the use and adverse effects of medicines and vaccines in real-world clinical use, working to the highest possible scientific standards.
All of our work seeks to facilitate the health and wellbeing of patients by putting the interests of patients first and protecting people from the hazards of medicines.
Values
Integrity, fairness, transparency and openness
We work with the highest possible scientific and ethical standards, and we adhere to relevant professional guidelines
We conduct our work with integrity, fairness, transparency and openness with all our partners
We value and respect diversity and all the people we work with
We respect the environment and promote sustainability
We seek to innovate the fields of pharmacovigilance and pharmacoepidemiology through collaboration, discussion and identification of the best way forward
We strive to inspire and support the next generation of pharmacovigilance scientists through our internationally renowned Education & Training courses
Pharmacovigilance
Independent Scientific Excellence
Our activities are principally concerned with pharmacovigilance, that is, the detection of side-effects associated with the use of marketed drugs. The DSRU undertakes and advises on all forms of non-interventional research studies and evaluations of the safety of medicines and provides education and training in pharmacovigilance and related subjects. We have achieved both recognition and endorsement by regulatory authorities, healthcare professionals, and pharmaceutical industry worldwide.
Who we are
An Independent Academic Unit
The DSRU is an independent academic unit and registered charity (No. 327206), as well as an Associate Department of the School of Pharmacy and Biomedical Sciences, University of Portsmouth.
The DSRU is led by Director, Professor Saad Shakir, and comprises a team of epidemiologists, physicians, pharmacists and biomedical scientists, supported by expert IT and administrative staff. The work of the DSRU is overseen by a panel of Trustees.
Partnerships between pharmaceutical companies are now commonplace for a range of activities. To ensure that all parties meet their obligations, many agreements need to include pharmacovigilance wording, either as part of contracts or more frequently as separate documents.
© 2024 coursetakers.com All Rights Reserved. Terms and Conditions of use | Privacy Policy